Upon pharmacological depletion of TAMs, T-cell infiltration and migration into the tumor islets were no longer impeded, and this enhanced the efficacy of anti-programmed cell death protein 1 (PD-1) immunotherapy (20). This evidence concerns the gene PDCD1 and neoplasm.